Tech Company Financing Transactions

Veracyte Funding Round

On 6/10/2010, Veracyte raised $28 million in Series B funding from Domain Associates, Kleiner Perkins Caufield & Byers and TPG Biotech.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

6000 Shoreline Ct. 300
San Francisco, CA 94080
USA

Phone

(650) 243-6300

Website

www.veracyte.com

Email Address

[email protected]

Overview

Veracyte (NASDAQ: VCYT) is pioneering the emerging field of molecular cytology. We are developing molecular tests designed to improve the diagnostic accuracy of cytology samples, thereby helping to increase the utility of these minimally invasive procedures as an alternative to surgical biopsy.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Bonnie Anderson

        

Chief Financial Officer

Giulia Kennedy

        

Chief Information Officer

Ashish Kheterpal

        

Chief Operating Officer

Christopher Hall

        

Chief Scientific Officer

Giulia Kennedy

        

VP - Bus. Development

John Hanna

        

Browse more venture capital transactions:

Prev: 6/10/2010: Modumetal venture capital transaction
Next: 6/10/2010: Collecta venture capital transaction

Share this article

News on VC Transactions

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary